A Phase 2b, comparative, two arm randomized, placebo-controlled, double blinded multi-centric study to Evaluate the Safety, Tolerability, and Efficacy of Oral Insulin 16 mg /day or placebo in subjects with Type 2 Diabetes Mellitus (DM) who are currently on diet alone or diet with monotherapy - Metformin up to 2.5 g/day
Phase of Trial: Phase II
Latest Information Update: 24 Aug 2016
At a glance
- Drugs Insulin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- 07 Sep 2011 Planned initiation date changed to 1 Jan 2009.
- 16 Sep 2008 New trial record.